// App-Quantinova.ai

1305 : Metabolism studies of SH7139, a small molecule drug targeting B-cell malignancies overexpressing HLA-DR10, confirm its prodrug function

Researchers

Presenter

  • Monique Cosman Balhorn

Principal Investigators

  • Rod Balhorn

Medical Centers

  • SHAL Technologies, Inc., Livermore, CA.

Locations

  • United States

Companies

  • SHAL Technologies, I

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Apparent diffusion coefficient

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved